Credit Suisse’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10,300
Closed -$1.18M 4289
2019
Q2
$1.18M Buy
+10,300
New +$1.21M ﹤0.01% 2828
2015
Q1
Sell
-15,450
Closed -$1.7M 4611
2014
Q4
$1.7M Sell
15,450
-90,537
-85% -$9.54M ﹤0.01% 2682
2014
Q3
$10.3M Sell
105,987
-208,369
-66% -$20.5M 0.01% 1268
2014
Q2
$31.7M Buy
+314,356
New +$30.7M 0.03% 686

Other funds holding ZBH

Credit Suisse's ZBH Position: Q1 2024 in Review

Credit Suisse reduced its Zimmer Biomet (ZBH) stake by 2.9% in Q1 2024, selling an estimated $1.39M and leaving 367,304 shares worth $48.1M. The position accounts for 0.05% of the portfolio, ranked #382.

Credit Suisse first reported a position in ZBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $159M in Q2 2014. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Credit Suisse held 367,304 shares of Zimmer Biomet worth $48.1M as of Q1 2024.
  • Credit Suisse sold 11,088 Zimmer Biomet shares in Q1 2024, an estimated $1.39M.
  • Zimmer Biomet made up 0.05% of Credit Suisse's portfolio in Q1 2024, its #382 holding.
  • Credit Suisse first reported a position in Zimmer Biomet in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Zimmer Biomet position peaked at $159M in Q2 2014.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.